|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, July 20, 2024 ) InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Biospecimen Contract Research Services Market Size, Share & Trends Analysis Report By Therapeutic Area (Oncological Disorders, Neurological Disorders, Cardiovascular Disorders, Other Therapeutic Areas), By Biospecimen Types
((Oncological Studies, FFPE Tissue, Frozen Tissue, Plasma / Serum, Other, Biospecimens), Non-Oncological Studies (Blood Products, Human Tissue, Other Biospecimens)) - Market Outlook and Industry Analysis 2031"
Download Free Demo Report: https://www.insightaceanalytic.com/request-sample/1264
Biospecimen Contract Research Services involve the collection, processing, storage, and analysis of biological samples (biospecimens) such as blood, tissue, urine, and other bodily fluids or materials for research purposes. These services are typically provided by specialized companies or organizations that offer their expertise to academic institutions, pharmaceutical companies, biotechnology firms, and other entities engaged in scientific research and drug development.
Biospecimen Contract Research Services (BCRS) companies act as a central source for researchers by procuring high-quality biological specimens, like blood or tissue, from patient registries, biobanks, and hospitals. These specimens are crucial for medical research but require careful processing and storage to maintain their integrity. BCRS providers have the expertise and facilities to not only store these specimens properly, but also perform various analyses on them, including genetic testing, protein analysis, and cell culture. By ensuring top quality throughout this process, BCRS firms play a vital role in accelerating medical advancements.
Biospecimen Contract Research Services are used in the analysis of tumor samples to identify genetic mutations and other alterations that drive cancer, and in investigating the role of the immune system in cancer and developing immunotherapies. By leveraging these services, researchers can obtain high-quality biological samples, process them efficiently, and conduct detailed analyses to uncover the genetic underpinnings of cancer. This information is crucial for the development of targeted therapies that specifically address the mutations driving tumor growth. he integration of genetic and immunological research through Biospecimen Contract Research Services is thus instrumental in advancing cancer treatment and improving patient outcomes.
List of Prominent Players in the Biospecimen Contract Research Services Market:
BioChain Institute
BioIVT
Boca Biolistics
Creative Bioarray
Cureline
Discovery Life Sciences
Infinity BiologiX
Precision for Medicine, Inc.,
PrecisionMed, Inc.,
Medicover,
National BioService,
ICON plc,
The MT Group,
Eolas Biosciences Co. Ltd,
Indivumed GmbH,
Ardent Clinical Research Services,
Capital Biosciences, Inc.,
GR BioResearch,
REPROCELL,
Trans-Hit Bio (Azenta US, Inc.)
iSpecimen
Market Dynamics:
Drivers-
The rise in chronic diseases such as cancer, diabetes, and cardiovascular conditions drives research efforts aimed at understanding these diseases better and developing effective treatments. Access to diverse and well-characterized biospecimens is essential for these research endeavors. As these industries expand, there is a heightened demand for reliable biospecimen collections to support drug discovery, development, and clinical trials. High-quality biospecimens are crucial for validating new drugs and therapies. Increasing collaboration between academic institutions, research organizations, and industry players fosters the need for centralized biospecimen services. Contract research organizations (CROs) provide the infrastructure and expertise for effective collaboration.
Challenges:
Establishing and maintaining standardized protocols across different sites and projects is a significant challenge. Managing the long-term storage of biospecimens while maintaining their integrity over time is challenging.
Regional Trends:
North America dominates the market. North America, particularly the United States, has a well-established biospecimen contract research services market. This is driven by significant investments in healthcare and biomedical research, robust infrastructure, and the presence of numerous pharmaceutical and biotechnology companies. Asia Pacific is the rapidly growth in biospecimen contract research services, driven by increasing investments in healthcare and biotechnology, particularly in countries like China, Japan, South Korea, and India.
Curious about this latest version of the report? @ https://www.insightaceanalytic.com/enquiry-before-buying/1264
Recent Developments:
In Feb. 2023, iSpecimen Inc., declared that the company has brought seven additional biospecimen providersfor both banked and prospectively obtained specimensto the iSpecimen Marketplaceฎ during the second half of 2022. With the support of these new suppliers, iSpecimen will be able to increase access to crucial biospecimens and data worldwide, which will facilitate the advancement of research in a number of fields, including cardiovascular, autoimmune, cancer, and infectious illnesses.
In September 2023, Indivumed Services GmbH, declared the acquisition of laboratory accreditation from the College of American Pathologists (CAP) for its Hamburg location. The CAP accreditation is only granted to elite laboratories that consistently achieve and exceed the highest requirements of quality, precision, and consistency in the testing of clinical biospecimens. It is widely acknowledged as the industry standard for laboratory quality control. With this achievement, Indivumed Services is positioned in the top 10% of laboratories worldwide, demonstrating its unwavering dedication to providing top-notch laboratory services.
Segmentation of Biospecimen Contract Research Services Market-
By Therapeutic Area
Oncological Disorders
Neurological Disorders
Cardiovascular Disorders
Other Therapeutic Areas
By Biospecimen Types
Oncological Studies
FFPE Tissue
Frozen Tissue
Plasma / Serum
Other Biospecimens
Non-Oncological Studies
Blood Products
Human Tissue
Other Biospecimens
By Region-
North America-
The US
Canada
Mexico
Europe-
Germany
The UK
France
Italy
Spain
Rest of Europe
Asia-Pacific-
China
Japan
India
South Korea
South East Asia
Rest of Asia Pacific
Latin America-
Brazil
Argentina
Rest of Latin America
Middle East & Africa-
GCC Countries
South Africa
Rest of Middle East and Africa
For More Customization @ https://www.insightaceanalytic.com/customisation/1264
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Insight Ace Analytics
Diana Dsouza
+8884144123
diana.dsouza@insightaceanalytics.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
